Dolby Laboratories Inc

For the period ended Dec 29, 2023. Filed Feb 2, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Dec 29, 2023 · Filed Feb 2, 2024

DLB$64.79-0.1%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Unaudited Interim Condensed Consolidated Balance Sheets

INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share amounts)

	December 29,2023	September 29,2023
ASSETS
Current assets:
Cash and cash equivalents	$656,816	$745,364
Restricted cash	51,842	72,602
Short-term investments	140,823	139,148
Accounts receivable, net of allowance for credit losses of $7,428 and $9,683	293,228	262,245
Contract assets, net of allowance for credit losses of $108 and $138	217,559	182,130
Inventories, net	37,568	35,623
Prepaid expenses and other current assets	53,519	50,692
Total current assets	1,451,355	1,487,804
Long-term investments	92,876	97,812
Property, plant, and equipment, net	479,321	481,581
Operating lease right-of-use assets	38,001	40,199
Intangible assets, net	159,894	167,427
Goodwill	410,435	408,409
Deferred taxes	206,667	201,860
Other non-current assets	96,980	94,674
Total assets	$2,935,529	$2,979,766
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$14,395	$20,925
Accrued liabilities	327,186	351,399
Income taxes payable	6,189	4,769
Contract liabilities	33,404	31,505
Operating lease liabilities	12,922	13,628
Total current liabilities	394,096	422,226
Non-current contract liabilities	36,994	39,997
Non-current operating lease liabilities	34,319	37,020
Other non-current liabilities	107,810	108,339
Total liabilities	573,219	607,582
Stockholders’ equity:
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 59,765,465 shares issued and outstanding at December 29, 2023 and 59,673,633 at September 29, 2023	53	53
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 36,085,779 shares issued and outstanding at December 29, 2023 and 36,085,779 at September 29, 2023	41	41
Retained earnings	2,367,182	2,391,990
Accumulated other comprehensive loss	(21,428)	(36,984)
Total stockholders’ equity – Dolby Laboratories, Inc.	2,345,848	2,355,100
Noncontrolling interest	16,462	17,084
Total stockholders’ equity	2,362,310	2,372,184
Total liabilities and stockholders’ equity	$2,935,529	$2,979,766

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.